This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Dr. Rado and Colleagues Reply

Jeffrey T. Rado, MD; Sheila Dowd, PhD; and Philip G. Janicak, MD

Published: July 31, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We agree with Dr. Kapoor’s assessment regarding thegrowing number of psychiatric and neurologic disorders forwhich transcranial magnetic stimulation (TMS) is proving useful. Of note, the recently published study of TMS was thelargest (N = 302) randomized, sham-controlled trial to demonstrateefficacy in patients with major depression. Further, thetreatment modality was well tolerated by a majority of patients,with a low incidence of side effects and a low discontinuationrate.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 69

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...